Chemotactic peptide N-formyl-met-leu-phe activation of p38 mitogen-activated protein kinase (MAPK) and MAPK-activated protein kinase-2 in human neutrophils
about
The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factorsPresence of the M-type sPLA(2) receptor on neutrophils and its role in elastase release and adhesionp38 Kinase-dependent MAPKAPK-2 activation functions as 3-phosphoinositide-dependent kinase-2 for Akt in human neutrophilsBiological role of the N-formyl peptide receptors5-lipoxygenase is phosphorylated by p38 kinase-dependent MAPKAP kinasesInvolvement of p38 mitogen-activated protein kinase signaling pathway in the rapid induction of the 78-kDa glucose-regulated protein in 9L rat brain tumor cellsThe Src family kinases Hck and Fgr regulate neutrophil responses to N-formyl-methionyl-leucyl-phenylalanineSerotonin Receptor 4/6/7 and NR3C SignalingSerotonin Receptor 2 and ELK-SRF/GATA4 signalingPhospholipase D is required in the signaling pathway leading to p38 MAPK activation in neutrophil-like HL-60 cells, stimulated by N-formyl-methionyl-leucyl-phenylalanine.Identification of the p16-Arc subunit of the Arp 2/3 complex as a substrate of MAPK-activated protein kinase 2 by proteomic analysis.Neutrophils stimulated with a variety of chemoattractants exhibit rapid activation of p21-activated kinases (Paks): separate signals are required for activation and inactivation of paks.Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathwaysProtein kinase C-delta regulates thrombin-induced ICAM-1 gene expression in endothelial cells via activation of p38 mitogen-activated protein kinase.Formyl peptide receptor as a novel therapeutic target for anxiety-related disordersDedifferentiation of adenocarcinomas by activation of phosphatidylinositol 3-kinase.Exocytosis of neutrophil granule subsets and activation of prolyl isomerase 1 are required for respiratory burst primingHypertonicity regulates the function of human neutrophils by modulating chemoattractant receptor signaling and activating mitogen-activated protein kinase p38.Ggamma in dictyostelium: its role in localization of gbetagamma to the membrane is required for chemotaxis in shallow gradients.Role of p38 in the priming of human neutrophils by peritoneal dialysis effluent.MAPK-activated protein kinase-2 (MK2)-mediated formation and phosphorylation-regulated dissociation of the signal complex consisting of p38, MK2, Akt, and Hsp27.COM crystals activate the p38 mitogen-activated protein kinase signal transduction pathway in renal epithelial cells.p90-RSK and Akt may promote rapid phosphorylation/inactivation of glycogen synthase kinase 3 in chemoattractant-stimulated neutrophils.Gene suppression by tristetraprolin and release by the p38 pathway.Possible involvement of heat shock protein 25 in the angiotensin II-induced glomerular mesangial cell contraction via p38 MAP kinase.Involvement of p38 mitogen-activated protein kinase in lipopolysaccharide-induced iNOS and COX-2 expression in J774 macrophages.Direct stimulation of Bruton's tyrosine kinase by G(q)-protein alpha-subunit.Characterization and partial purification of a novel neutrophil membrane-associated kinase capable of phosphorylating the respiratory burst component p47phox.Enhancement of chemotactic peptide-induced activation of phosphoinositide 3-kinase by granulocyte-macrophage colony-stimulating factor and its relation to the cytokine-mediated priming of neutrophil superoxide-anion productionActivation of mitogen-activated protein kinases by formyl peptide receptors is regulated by the cytoplasmic tail.A role for the p38 mitogen-activated protein kinase/Hsp 27 pathway in cholecystokinin-induced changes in the actin cytoskeleton in rat pancreatic acini.Protein O-GlcNAc modulates motility-associated signaling intermediates in neutrophils.Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: a role in cardiac myocyte hypertrophy?Activation of mitogen-activated protein kinases (p38-MAPKs, SAPKs/JNKs and ERKs) by the G-protein-coupled receptor agonist phenylephrine in the perfused rat heart.fMLP-Induced IL-8 Release Is Dependent on NADPH Oxidase in Human Neutrophils.Ionomycin causes activation of p38 and p42/44 mitogen-activated protein kinases in human neutrophils.Oxalate selectively activates p38 mitogen-activated protein kinase and c-Jun N-terminal kinase signal transduction pathways in renal epithelial cells.Hypertonicity increases cAMP in PMN and blocks oxidative burst by PKA-dependent and -independent mechanisms.Ligand density modulates eosinophil signaling and migration.Distinct ligand-dependent roles for p38 MAPK in priming and activation of the neutrophil NADPH oxidase.
P2860
Q24291136-145B2AE8-313C-4B76-B308-6160C847BC3DQ24306613-B96B84D1-8FF3-4B6B-9EE2-ADD3C3EEC967Q28141837-312905F3-46B6-4C04-9C83-13F25D5F07B2Q28239162-385D9F33-7E59-49DA-A72E-97997362CDB1Q28344173-0B4BB9ED-0530-4CCE-AA65-D0FC7521933BQ28611457-D56B5808-9EBE-44E2-85B6-13150D2AC1BEQ28646167-8B32D92B-C666-410F-BA6A-D523E22904C7Q30230753-6B165957-1E7D-4EB5-B6AE-491E8A0C6C6CQ30230906-17E27971-7C35-437D-9E0E-7E92766729E3Q33182166-0D83FF39-82A4-460D-BAE6-7D8FEB236886Q33187562-F1526073-4BD2-4DF9-A3E5-AB41A709D73CQ33781697-CAEFA60B-99E0-4758-A6F6-C6E1E3D1B27AQ33834722-F6334AF2-F3CE-436E-A46A-65ABA53BD1AFQ33969238-CD9AC94A-6DB1-4832-8A14-714BD7B0BDABQ35526848-EC04D468-85AE-4567-9047-58EEC7D970B2Q36332574-FA73EFF8-9522-49F9-B640-9A178C456820Q36953305-B79AA9CD-44B5-4BBC-B83E-F60C2E4688EDQ37383582-BA074F26-2BD0-4B11-B9FA-5E7BA102DB48Q39227132-42590358-2AE9-4620-B67B-8CC850E454D7Q39506731-BDFB0EF1-337A-4D98-A9DA-2D7B308A3D30Q40224907-92C20886-4566-4E61-987F-6E84ECC50FDBQ40717860-27340121-51C1-40A2-ADB4-ED36633FFFD4Q40777313-57D74372-A5D5-4915-9462-A53F7F39E4E0Q40795321-15F081FB-9AEF-472A-AD1B-A8C07FA3843FQ40922000-DA068A89-8ECF-487F-9BAB-8B248BECBD16Q40935358-BB500DE0-76FD-4507-8E70-BE4B4C477EA4Q41090124-2E37AAD4-26AC-4B50-A18B-C3944FB295AFQ42114061-D47B3846-053E-4487-BB8D-7ED38673B7C0Q42159024-77C0B286-1CE2-4F64-8BAA-BD00932656ECQ42459406-9BC388DF-D251-497E-AD90-7BF95DF13506Q42460744-A9F1104A-70EF-4EA2-B676-7944A0951C6AQ42474134-66CBF16A-DBAF-40FE-BA4B-A4CCA04E4ED3Q42797088-2AB7153C-B38F-4446-9B02-456E40B94F15Q42990783-9F033B0A-1C90-4383-BEF3-DA4AA409F5CDQ43161282-19117113-34A3-4E75-9E5A-CF1D13407F09Q43636843-093FC698-35FC-43CB-9CF0-55697A8CAA81Q43874023-F907F9D0-1786-4380-8CA8-1B7E945208A1Q43984416-3AF62DF9-6753-497D-84C3-9A4726F6B403Q44417204-2996B48B-F000-43EA-BF35-19882AAEE332Q44854782-78D9157D-1FB2-4418-BD14-2614B0044876
P2860
Chemotactic peptide N-formyl-met-leu-phe activation of p38 mitogen-activated protein kinase (MAPK) and MAPK-activated protein kinase-2 in human neutrophils
description
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 1997
@ast
im Januar 1997 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1997/01/10)
@sk
vědecký článek publikovaný v roce 1997
@cs
wetenschappelijk artikel (gepubliceerd op 1997/01/10)
@nl
наукова стаття, опублікована в січні 1997
@uk
name
Chemotactic peptide N-formyl-m ...... kinase-2 in human neutrophils
@ast
Chemotactic peptide N-formyl-m ...... kinase-2 in human neutrophils
@en
Chemotactic peptide N-formyl-m ...... kinase-2 in human neutrophils
@nl
type
label
Chemotactic peptide N-formyl-m ...... kinase-2 in human neutrophils
@ast
Chemotactic peptide N-formyl-m ...... kinase-2 in human neutrophils
@en
Chemotactic peptide N-formyl-m ...... kinase-2 in human neutrophils
@nl
prefLabel
Chemotactic peptide N-formyl-m ...... kinase-2 in human neutrophils
@ast
Chemotactic peptide N-formyl-m ...... kinase-2 in human neutrophils
@en
Chemotactic peptide N-formyl-m ...... kinase-2 in human neutrophils
@nl
P2093
P2860
P356
P1476
Chemotactic peptide N-formyl-m ...... kinase-2 in human neutrophils
@en
P2093
J. S. Sanghera
S. Grinstein
S. L. Pelech
P2860
P304
P356
10.1074/JBC.272.2.937
P407
P577
1997-01-10T00:00:00Z